HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: a study from Hepatitis Clinic of Iranian Blood Transfusion Organization.

AbstractBACKGROUND:
Hepatitis B is a significant health problem and more than 350 million individuals are infected with hepatitis B virus (HBV) globally. About 5% of these individuals are coinfected with hepatitis D virus (HDV). HBV-HDV coinfection increases the rate of fulminant hepatitis, chronic hepatitis and cirrhosis. This study aimed to evaluate the epidemiology of HDV in individuals positive for hepatitis B surface antigen (HBsAg) who were referred to Tehran Blood Transfusion Hepatitis Clinic from 2011 to 2012.
MATERIALS AND METHODS:
HBsAg-positive individuals attending this clinic were tested for anti-HDAg antibodies (anti-HDAbs). All samples positive for anti-HDAb were also tested for detection of HDV RNA by reverse transcription-polymerase chain reaction (RT-PCR). A questionnaire consisting of demographic characteristics and potential risk factors for acquisition of HDV was filled for each individual.
RESULTS:
Among 1038 individuals, HBsAg was detected in 660 (63.6%) cases following blood donation and in 378 (36.4%) cases following blood testing. In this study, 23 [2.2%, 95% confidence interval (CI) = 1.3-3.2%] patients were HDV-seropositive. In HDV-seropositive patients, 14 (60.9%, 95% CI = 39.1-78.3%) were positive for HDV RNA. HDV-seropositive cases were more likely to have evidence of severe forms of hepatitis than the group of individuals without anti-HDAb (P < 0.01). Familial history of hepatitis D infection was more observed in HDV-seropositive patients than in individuals negative for anti-HDAb (P < 0.01).
CONCLUSION:
The seroprevalence of HDV in HBsAg-positive individuals in this study was about 2% which seems to be lower than the global prevalence of HDV.
AuthorsM Keshvari, S M Alavian, B Aghaee, B Behnava, M Mahdavi, M Gholami Fesharaki, H Sharafi
JournalTransfusion medicine (Oxford, England) (Transfus Med) Vol. 24 Issue 6 Pg. 411-7 (Dec 2014) ISSN: 1365-3148 [Electronic] England
PMID25523297 (Publication Type: Clinical Trial, Journal Article)
Copyright© 2014 British Blood Transfusion Society.
Chemical References
  • Hepatitis B Surface Antigens
  • RNA, Viral
Topics
  • Adult
  • Aged
  • Blood Donors
  • Coinfection (blood, epidemiology)
  • Female
  • Hepatitis B (blood, epidemiology)
  • Hepatitis B Surface Antigens (blood)
  • Hepatitis D (blood, epidemiology)
  • Hepatitis Delta Virus
  • Hospitals, Special
  • Humans
  • Iran
  • Male
  • Middle Aged
  • RNA, Viral (blood)
  • Seroepidemiologic Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: